Quote:
Originally Posted by
by-the-lakeÂ

Here is some info on the P17 FDA patent
Â
FDA approved a commercial form of the drug, called Makena, manufactured by K-V Pharmaceutical Co. of St. Louis. The company said Wednesday that the drug will be available for shipping March 14 and that it will cost $1,500 per dose.
Â
Can you ask you doc if oral or vaginal progesterone can be prescribed? The thing my doc explained to me about any drug involving a fetus is unethical, and data gathered to make certain assertions of effacity are collected in all circumstances, meaning there is really no 'control group' in which to conduct this research.
Â
I wonder in your instance, it may be impossible to determine if the preterm labor or abruption came first. I have more commonly seen where an abruption triggered preterm labor, because when an abruption occurs, the body goes into labor. I think this is the body's way to protect itself, because an abruption can cause maternal and fetal death, so the body kicks i to labor to 'get rid of the issue'. Make sense? The abruption may not be apparent until after delivery sometimes.
I totally think you're right about the abruption triggering PTL. That is my gut feeling but I guess I will never know for sure because there was no sign of placental abruption until examining the placenta.
Â
After going back on the Makena website though, there is no way in hell I'm doing the shots. Here is the link http://www.makena.com//media/PDFs/full-pi.pdf . They actually did use a control group. Here is what they say on their own website... There were 306 women in the study who received the shot and 156 who received a shot that was a placebo, so the control group. You can go in and see the chart which is on the fourth page, but here it is in a nutshhell..
Â
Makena Miscarriages <20 weeks gestation C 5 (2.4%) versus 0 miscarriages in the control group
Stillbirth 6 (2.0%) versus 2 in the control group (1.3%)
Antepartum stillbirth 5 (1.6%) versus  1 in the control group (0.6%)
Intrapartum stillbirth 1 (0.3%) versus 1 in the control group (0.6%)
Neonatal deaths 8 (2.6%) versus 9 in the control group (5.9%)
Total Deaths including miscarriages prior to 20 weeks 19 (6.2%) versus 11 in control group (7.2%)Â
Â
They state themselves:Â Due to the higher rate of miscarriages and stillbirths in the Makena arm, there was no overall survival difference demonstrated in this clinical trial.Â
Â
They also do show the stats where women definitely are delivering later in their pregnancies on the shots, so their claim that the shots prevent PTL are true and accurate, but I think it is a pretty big deal that there is actually no statistical difference in the total losses, and there are more stillbirths and miscarriages in the group taking the shot. Those who were able to carry their babies longer didn't have any better outcomes. They just prevented PTL but experienced the statistical same amount of loss.Â
Â
UGH. These shots seemed like the magic trick. I guess i will have to look into continuing the progesterone suppositories and see if they have the same risks or have even been studied like this. Thanks everyone for your help!Â
Â